Chondroblastoma associated with aneurysmal cyst of the navicular bone: a case report
© Zhenhua and Ming.; licensee BioMed Central Ltd. 2013
Received: 12 October 2012
Accepted: 16 February 2013
Published: 28 February 2013
Chondroblastoma is a rare tumor. It is usually benign; however, it can have an aggressive course before or after operative treatment, even resulting in pulmonary metastases. The foot is a rare location for chondroblastoma, and to our knowledge, chondroblastoma occurring in the navicular bone has not been reported previously in the English literature. We describe a case of navicular chondroblastoma case associated with an aneurysmal bone cyst. Treatment consisted of aggressive curettage, phenolization, and bone allograft. The patient was able to resume normal activities after treatment, and there was no recurrence of the chondroblastoma during a follow-up of 3 years.
Chondroblastoma was first identified by Jaffe and Lichtenstein in 1942. It is a rare and usually benign bone tumor, which accounts for approximately 1% of all benign bone tumors. There is a male preponderance, and there is a relatively higher frequency of chondroblastoma in the epiphyses of the long bones in adolescents. The two most common tumor locations are the proximal humerus and proximal tibia, with a male:female ratio of 2:1[2–4]. Generally, the foot is a rare location for chondroblastoma, and approximately 20% of foot chondroblastomas occur in the calcaneus and talus bones. In addition, there have been a few reported cases of chondroblastoma occurring on the cuboid bones[3, 6, 7]. To our knowledge, chondroblastoma of the navicular bone has not been reported previously in the English literature.
We report a case of and successful management of a navicular chondroblastoma associated with an aneurysmal bone cyst.
A 24-year-old woman presented to the local clinic with pain in her left foot. She denied having any recent fevers, and she did not have any history of foot or ankle trauma. The rest of her medical history was not significant. The patient was initially treated conservatively with medication and rest. However, the pain gradually worsened, and began to be apparent even at rest. At this stage (about 6 months after her initial presentation), the patient was referred to our clinic for further treatment.
During the physical examination, the patient reported tenderness in the region of the navicular bone in her left foot, but there was no palpable mass in this area, and the temperature of the skin over the navicular bone was normal. The patient was unable to bear weight on her left foot, and the motor function of the foot was difficult to assess because of the pain.
A biopsy was taken from the lesion. An 18-gauge needle was used to puncture the lesion, and blood was aspirated easily from the lesion. Baseline chest radiography was also performed at this point. The result is that the blood in the lesion. Our result also based on these results).
The patient returned to her usual daily activities without pain. She had full range of motion of the mid-tarsal joints. She underwent follow-up including radiography at 3-month intervals for 1 year. Thereafter, radiographs were obtained biannually for 3 years, and yearly until she had completed 5 years of post-operative follow-up. At the 3-year follow-up, she was asymptomatic and there was no evidence of recurrence.
Chondroblastoma is a rare lesion. The majority (70%) of cases occur in the long bones, including the proximal humerus, proximal tibia. and femur. The small bones are involved in only 10% of cases. In this paper, we present a case of navicular chondroblastoma associated with an aneurysmal bone cyst. The successful treatment consisted of aggressive curettage, phenolization, and allograft reconstruction.
Pain was the main and presenting symptom in our case, which is compatible with previous reports[2, 4]. Because of the frequent occurrence of this tumor near joints, effusion can be present in some patients. For this reason, chondroblastoma is often misdiagnosed as an inflammatory joint disease. Atalar et al. reported a patient who had initially been misdiagnosed with a juvenile rheumatoid arthritis, and had undergone anti-inflammatory therapy for 1 year before the correct diagnosis was made. In our case, there was a six-month interval from the initial symptoms of pain to the suspicion of chondroblastoma, supporting the opinion that chondroblastoma is easily misdiagnosed.
In terms of the differential diagnosis, chondroblastoma should be distinguished from a number of other conditions. Giant-cell tumor is one possibility, but the tissue margins of chondroblastoma tend to be more clearly visible on imaging. Chondroma, central chondrosarcoma and clear-cell chondrosarcoma can resemble chondroblastoma. Similar to chondroblastoma, clear-cell chondrosarcoma often involves the ends of the long bones; however, it tends to occur in middle-aged patients, whereas chondroblastoma tends to occur in young patients. Epiphyseal enchondroma has many points in common with chondroblastoma in terms of patient age and the skeletal distribution and location of the tumor; however, histological examination can be used to distinguish between them. 4) Inflammatory joint disease is another possibility. Pain was the presenting symptom, Due to its more frequent occurrence near joints, chondroblastoma can present with joint pain and effusion. For this reason, it can be misdiagnosed as inflammatory joint disease.
Conventional radiographs can be helpful as an initial survey of a painful region. The involvement of the tarsal bones with cortical expansion and related erosive changes in the cortex is an indication of chondroblastoma. Usually, the lesion is located in secondary ossification centers. Altalar et al. reported that calcification in chondroblastoma was visible on radiographs in 59.4% of cases. A baseline chest radiograph should be obtained before diagnosis or surgery, and the diagnosis should be confirmed by biopsy. Annual chest radiographs should be performed for 5 years after treatment to monitor for pulmonary metastasis, which occurs in 1 to 3% of patients. We should emphasize that the chondroblastoma might already display aggressive behavior at an early stage. A bone scan may also be helpful to exclude other areas of skeletal involvement. Magnetic resonance imaging may be helpful to identify whether a soft-tissue mass is present.
Chondroblastoma is typically a slow-growing tumor[3, 6, 7]. Rarely, the tumor can grow rapidly, destroying the cortex and invading the soft tissues. However, Altalar et al. reported that cortical destruction and soft-tissue invasion were seen in 13/32 patients with chondroblastoma. Our patient had no evidence of soft-tissue invasion. Secondary aneurysmal bone cysts have been reported by other authors[4, 8], and this was also seen in our patient.
Atalar et al. reported that local recurrence of chondroblastoma occurred in about 21.4% of their patients during the long-term follow-up. This recurrence rate is consistent with those in other studies[2, 9]. Suneja et al. reported that invasion of an open growth plate (physis) might imply the increase risk for local recurrence. However, Atalar et al. analyzed potential risk factors for recurrence in 28 patients, and did not find that young age or the presence of an open physis to be associated with local recurrence. Nevertheless, controversy exists about what risk factors are associated with recurrence. The risk of recurrence has been reported as being higher in the hip and the pelvis, as a result of the difficult surgical access, but Suneja et al. and Atalar et al.[2, 4] reported that there was no association between tumor location and recurrence. Generally, recurrence of chondroblastoma doe not seem to be associated with age, sex, tumor location, growth-plate status, or tumor activity.
In previous reports, it was suggested that surgical techniques can play a crucial role in chondroblastoma recurrence, as the actual removal of the tumor seems to be an important factor[2, 4, 8]. Simple curettage seems to result in a relatively higher recurrence rate compared with a standard curettage procedure. A combination of curettage and cryosurgery was recommended by Schreuder et al., which they reported as contributing to reducing the likelihood of recurrence. Lin et al. reported that use of a burr could aid in extending the curettage, particularly in areas that are difficult to access. Atalar et al. recommended cautery as a powerful tool in areas that were difficult to reach areas, as the heat generated could kill the tumor cells. A number of other surgical techniques are also available, including open and endoscopic curettage, curettage with fat implantation, marginal resection, resection with radiofrequency ablation, and osteochondral autograft transfer[8, 12–14].
How to reconstruct the bone defect after surgery is another issue. Use of cement, bone graft, and other alternatives has been reported previously[6, 14]. Sessions et al. reported successful reconstruction using cement in cases of cuboid tumor. Reconstruction with cement can make immediate weight-bearing possible without risk of fracture, and can improve radiographic follow-up. However, the bone graft may resorb, making it difficult to differentiate the graft from a tumor recurrence. The long-term effect of cement on the articular surface of the bone remains unknown, but it is possible that arthritis may develop, due to the non-anatomical construction of the cement. At present, biological reconstruction using bone graft seems to be the best option, with good results reported by a number of authors[2, 4, 8]. The most common option for reconstruction after tumor excision is bone autograft harvested from iliac crest or fibula. The advantages of autograft include improved rate of graft incorporation and lack of immunogenic concerns[4, 5]; however, it may need a longer operating time and can result in donor morbidity. Use of allografot is an alternative option, which has been used for treatment of tumors in the calcaneus and talus bones[15, 16]. However, fracture and non-union are common complications for allografts. There is also a risk of transmitting disease with allograft; however, with safety precautions, including donor selection and biological investigations, such risks are low. In the present case, there were no complications related to the allograft.
Generally, it is well accepted that aggressive curettage and bone graft are the preferred treatment for chondroblastoma[2, 4, 8]. In our case, our successful treatment consisted of an open biopsy followed by curettage, phenolization, and allograft. This case appears to be the first case of chondroblastoma occurring in the navicular bone. We hope this report will increase the awareness of this rare tumor occurring in the foot.
Writing informed consent was obtained from the patient for publication of this case report and accompanying images.
- Jaffe HL, Lichtenstein L: Benign chondroblastoma of bone: a reinterpretation of the so-called calcifying or chondromatous giant cell tumor. Am J Pathol. 1942, 18: 969-991.PubMed CentralPubMedGoogle Scholar
- Suneja R, Grimer RJ, Belthur M, Jeys L, Carter SR, Tillman RM, Davies AM: Chondroblastoma of bone: long-term results and functional outcome after intralesional curettage. J Bone Joint Surg Br. 2005, 87: 974-978.View ArticlePubMedGoogle Scholar
- Kyriakos M, Land VJ, Penning HL, Parker SG: Metastatic chondroblastoma. Report of a fatal case with a review of the literature on atypical, aggressive, and malignant chondroblastoma. Cancer. 1985, 55: 1770-1789. 10.1002/1097-0142(19850415)55:8<1770::AID-CNCR2820550825>3.0.CO;2-Q.View ArticlePubMedGoogle Scholar
- Atalar H, Basarir K, Yildiz Y, Erekul S, Saglik Y: Management of chondroblastoma: retrospective review of 28 patients. J Orthop Sci. 2007, 12: 334-340. 10.1007/s00776-007-1141-2.View ArticlePubMedGoogle Scholar
- Ramappa AJ, Lee FY, Tang P, Carlson JR, Gebhardt MC, Mankin HJ: Chondroblastoma of bone. J Bone Joint Surg Am. 2000, 82: 1140-1145. 10.1302/0301-620X.82B8.10791.View ArticlePubMedGoogle Scholar
- Sessions W, Siegel H, Thomas J, Pitt M, Saidalnaief N, Casillasjr M: Chondroblastoma with associated aneurysmal bone cyst of the cuboid. J Foot Ankle Surg. 2005, 44: 64-67. 10.1053/j.jfas.2004.11.010.View ArticlePubMedGoogle Scholar
- Sepah YJ, Umer M, Minhas K, Hafeez K: Chondroblastoma of the cuboid with an associated aneurysmal bone cyst: a case report. J Med Case Reports. 2007, 1: 135-10.1186/1752-1947-1-135.PubMed CentralView ArticleGoogle Scholar
- Lin PP, Thenappan A, Deavers MT, Lewis VO, Yasko AW: Treatment and prognosis of chondroblastoma. Clin Orthop Relat Res. 2005, 438: 103-109.View ArticlePubMedGoogle Scholar
- Campanacci MBF, Bacchini P: Bone and soft tissue tumors. Tumori delle ossa e delle parti molli. Edited by: Notini S. 1990, New York: Springer-Verlag, 241-252.Google Scholar
- Potter BK, Freedman BA, Lehman RA, Shawen SB, Kuklo TR, Murphey MD: Solitary epiphyseal enchondromas. J Bone Joint Surg Am. 2005, 87: 1551-1560. 10.2106/JBJS.D.02404.View ArticlePubMedGoogle Scholar
- Schreuder HW, Pruszczynski M, Veth RP, Lemmens JA: Treatment of benign and low-grade malignant intramedullary chondroid tumours with curettage and cryosurgery. Eur J Surg Oncol. 1998, 24: 120-126. 10.1016/S0748-7983(98)91459-7.View ArticlePubMedGoogle Scholar
- Dahlin DC, Ivins JC: Benign chondroblastoma. A study of 125 cases. Cancer. 1972, 30: 401-413. 10.1002/1097-0142(197208)30:2<401::AID-CNCR2820300216>3.0.CO;2-B.View ArticlePubMedGoogle Scholar
- Anderson AF, Ramsey JR: Chondroblastoma of the talus treated with osteochondral autograft transfer from the lateral femoral condyle. Foot Ankle Int. 2003, 24: 283-287.PubMedGoogle Scholar
- Sterling G, Wilson A: Chondroblastoma of the talus: a case report. J Foot Ankle Surg. 2002, 41: 178-182. 10.1016/S1067-2516(02)80068-0.View ArticlePubMedGoogle Scholar
- Myerson MS, Neufeld SK, Uribe J: Fresh-frozen structural allografts in the foot and ankle. J Bone Joint Surg Am. 2005, 87: 113-120. 10.2106/JBJS.C.01735.View ArticlePubMedGoogle Scholar
- Rubel IF, Carrer A: Fresh-frozen osteochondral allograft reconstruction of a severely fractured talus. A case report. J Bone Joint Surg Am. 2005, 87: 625-629. 10.2106/JBJS.C.01671.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.